Paroxysmal hypertension: The role of stress and psychological factors

Journal of Clinical Hypertension

Volumn 10, Issue 7, 2008, Pages 575-581

  Pickering, Thomas G ^a,b   Clemow, Lynn ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b New York Presbyterian Hospital Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; CATECHOLAMINE; CLONAZEPAM; CLONIDINE; DOPAMINE; HYDROCHLOROTHIAZIDE; NORADRENALIN; SEROTONIN UPTAKE INHIBITOR;

ADRENALIN BLOOD LEVEL; ADRENERGIC SYSTEM; AGED; ANXIETY DISORDER; BLOOD PRESSURE MONITORING; BREATHING EXERCISE; CASE REPORT; CATECHOLAMINE BLOOD LEVEL; COGNITIVE BEHAVIOR PANIC MANAGEMENT; COGNITIVE THERAPY; DIZZINESS; EPIGASTRIC PAIN; FEMALE; FLUSHING; FOLLOW UP; HUMAN; HYPERTENSION; HYPERVENTILATION SYNDROME; NAUSEA; NERVOUSNESS; NORADRENALIN BLOOD LEVEL; PANIC; PATHOGENESIS; PHEOCHROMOCYTOMA; PHYSICIAN ATTITUDE; POLYURIA; PRIORITY JOURNAL; PSEUDOPHEOCHROMOCYTOMA; PSYCHOEDUCATION; PSYCHOLOGICAL ASPECT; REVIEW; STRESS; SWEATING; SYSTOLIC BLOOD PRESSURE; WEAKNESS; HYPERVENTILATION; MENTAL STRESS; PATHOPHYSIOLOGY; RISK FACTOR;

AGED, 80 AND OVER; FEMALE; HUMANS; HYPERTENSION; HYPERVENTILATION; PANIC DISORDER; PHEOCHROMOCYTOMA; RISK FACTORS; STRESS, PSYCHOLOGICAL;

EID: 54449101773     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2008.07844.x     Document Type: Review

References (49)

1. Kuchel O. Pseudopheochromocytoma. Hypertension. 1985;7(1):151-158.
2. Kuchel O. New insights into pseudopheochromocytoma and emotionally provoked hypertension. In: Mansoor GA, ed. Secondary Hypertension. Clinical Presentation, Diagnosis, and Treatment. Totowa, NJ: Humana Press; 2004:251-276.
3. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. Washington, DC: American Psychiatric Association; 1980.
4. Mann SJ. Severe paroxysmal hypertension (pseudopheochromocytoma): understanding the cause and treatment. Arch Intern Med. 1999;159(7):670-674.
5. Bryant RA, Panasetis P. Panic symptoms during trauma and acute stress disorder. Behav Res Ther. 2001;39(8):961-966.
6. Katon WJ. Clinical practice. Panic disorder. N Engl J Med. 2006;354(22):2360-2367.
7. Reed V, Wittchen HU. DSM-IV panic attacks and panic disorder in a community sample of adolescents and young adults: How specific are panic attacks? J Psychiatr Res. 1998;32(6):335-345.
8. Fava GA, Mangelli L. Subclinical symptoms of panic disorder: New insights into pathophysiology and treatment. Psychother Psychosom. 1999;68(6):281-289.
9. Kawachi I, Sparrow D, Vokonas PS, et al. Symptoms of anxiety and risk of coronary heart disease. The Normative Aging Study. Circulation. 1994;90(5):2225-2229.
10. Smoller JW, Pollack MH, Wassertheil-Smoller S, et al. Panic Attacks and Risk of Incident Cardiovascular Events Among Postmenopausal Women in the Women's Health Initiative Observational Study. Arch Gen Psychiatry. 2007;64(10):1153-1160.
11. Shioiri T, Someya T, Murashita J, et al. The symptom structure of panic disorder: A trial using factor and cluster analysis. Acta Psychiatr Scand. 1996;93(2):80-86.
12. Diagnostic and Statistical Manual of Mental Disorders: DSM IV. Washington, DC: American Psychiatric Association; 1994.
13. Meisel SR, Kutz I, Dayan KI, et al. Effect of Iraqi missile war on incidence of acute myocardial infarction and sudden death in Israeli civilians. Lancet. 1991;338(8768):660-661.
14. Shear MK, Polan JJ, Harshfield GA, et al. Ambulatory monitoring of blood pressure and heart rate in panic patients. J Anxiety Disord. 1992;6:213-221.
15. White WB, Baker LH. Episodic hypertension secondary to panic disorder. Arch Intern Med. 1986;146(6):1129-1130.
16. Craske MG, Lang AJ, Mystkowski JL, et al. Does nocturnal panic represent a more severe form of panic disorder? J Nerv Ment Dis. 2002;190(9):611-618.
17. Davies SJ, Ghahramani P, Jackson PR, et al. Panic disorder, anxiety and depression in resistant hypertension: A case-control study. J Hypertens. 1997;15(10):1077-1082.
18. Davies SJ, Ghahramani P, Jackson PR, et al. Association of panic disorder and panic attacks with hypertension. Am J Med. 1999;107(4):310-316.
19. Katon W. Panic disorder and somatization. Review of 55 cases. Am J Med. 1984;77(1):101-106.
20. Wells KB, Golding JM, Burnam MA. Chronic medical conditions in a sample of the general population with anxiety, affective, and substance use disorders. Am J Psychiatry. 1989;146(11):1440-1446.
21. Wilkinson DJ, Thompson JM, Lambert GW, et al. Sympathetic activity in patients with panic disorder at rest, under laboratory mental stress, and during panic attacks. Arch Gen Psychiatry. 1998;55(6):511-520.
22. Villacres EC, Hollifield M, Katon WJ, et al. Sympathetic nervous system activity in panic disorder. Psychiatry Res. 1987;21(4):313-321.
23. Esler M, Lambert E, Alvarenga M, et al. Increased brain serotonin turnover in panic disorder patients in the absence of a panic attack: Reduction by a selective serotonin reuptake inhibitor. Stress. 2007;10(3):295-304.
24. Alvarenga ME, Richards JC, Lambert G, et al. Psychophysiological mechanisms in panic disorder: A correlative analysis of noradrenaline spillover, neuronal noradrenaline reuptake, power spectral analysis of heart rate variability, and psychological variables. Psychosom Med. 2006;68(1): 8-16.
25. Lambert EA, Thompson J, Schlaich M, et al. Sympathetic and cardiac baroreflex function in panic disorder. J Hypertens. 2002;20(12):2445-2451.
26. Klein DF. False suffocation alarms, spontaneous panics, and related conditions. An integrative hypothesis. Arch Gen Psychiatry. 1993;50(4):306-317.
27. Leor J, Poole WK, Kloner RA. Sudden cardiac death triggered by an earthquake. N Engl J Med. 1996;334(7):413-419.
28. Abrams K, Rassovsky Y, Kushner MG. Evidence for respiratory and nonrespiratory subtypes in panic disorder. Depress Anxiety. 2006;23(8):474-481.
29. Preter M, Klein DF. Panic, suffocation false alarms, separation anxiety and endogenous opioids. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(3):603-612.
30. Muller JE, Kaufmann PG, Luepker RV, et al. Mechanisms precipitating acute cardiac events: Review and recommendations of an NHLBI workshop. National Heart, Lung, and Blood Institute. Mechanisms Precipitating Acute Cardiac Events Participants. Circulation. 1997;96(9):3233-3239.
31. Kaplan NM. Anxiety-induced hyperventilation: A common cause of symptoms in patients with hypertension. Arch Intern Med. 1997;157:945-948.
32. Papp LA, Martinez JM, Klein DF, et al. Respiratory psychophysiology of panic disorder: Three respiratory challenges in 98 subjects. Am J Psychiatry. 1997;154(11):1557-1565.
33. Roth WT. Physiological markers for anxiety: Panic disorder and phobias. Int J Psychophysiol. 2005;58(2-3):190-198.
34. Wilhelm FH, Gerlach AL, Roth WT. Slow recovery from voluntary hyperventilation in panic disorder. Psychosom Med. 2001;63(4):638-649.
35. Gorman JM, Fyer MR, Goetz R, et al. Ventilatory physiology of patients with panic disorder. Arch Gen Psychiatry. 1988;45(1): 31-39.
36. Hornsveld HK, Garssen B, Dop MJ, et al. Double-blind placebo-controlled study of the hyperventilation provocation test and the validity of the hyperventilation syndrome. Lancet. 1996;348(9021):154-158.
37. Beck JG, Wolf MS. Response to repeated CO2 in individuals with elevated anxiety sensitivity: Replication with 20% CO2. J Behav Ther Exp Psychiatry. 2001;32(1):1-16.
38. Burnum JF, Hickam JB, McIntosh HD. Effect of hypocapnia on arterial blood pressure. Circulation. 1954;9:89-95.
39. Todd GP, Chadwick IG, Yeo WW, et al. Pressor effect of hyperventilation in healthy subjects. J Hum Hypertens. 1995;9(2):119-122.
40. Fontana F, Bernardi P, Lanfranchi G, et al. Blood pressure response to hyperventilation test reflects daytime pressor profile. Hypertension. 2003;41(2):244-248.
41. Martinez JM, Coplan JD, Browne ST, et al. Hemodynamic response to respiratory challenges in panic disorder. J Psychosom Res. 1998;44(1):153-161.
42. Manger WM, Gifford RW. Clinical and Experimental Pheochromocytoma. 2nd ed. Cambridge, MA: Blackwell Science; 1996.
43. Davies SJ, Jackson PR, Ramsay LE, et al. No evidence that panic attacks are associated with the white coat effect in hypertension. J Clin Hypertens (Greenwich). 2003;5(2):145-152.
44. van den Hout MA, Hoekstra R, Arntz A, et al. Hyperventilation is not diagnostically specific to panic patients. Psychosom Med. 1992;54(2):182-191.
45. Rapee R. Differential response to hyperventilation in panic disorder and generalized anxiety disorder. J Abnorm Psychol. 1986;95(1):24-28.
46. Kudva YC, Sawka AM, Young WF Jr. Clinical review 164: The laboratory diagnosis of adrenal pheochromocytoma: The Mayo Clinic experience. J Clin Endocrinol Metab. 2003;88(10):4533-4539.
47. Vaclavik J, Stejskal D, Lacnak B, et al. Free plasma metanephrines as a screening test for pheochromocytoma in low-risk patients. J Hypertens. 2007;25(7):1427-1431.
48. Mancia G, Ferrari A, Gregorini L, et al. Blood pressure and heart rate variabilities in normotensive and hypertensive human beings. Circ Res. 1983;53(1):96-104.
49. Imai Y, Aihara A, Ohkubo T, et al. Factors that affect blood presure variability. A community-based study in Ohasama, Japan. Am J Hypertens. 1997;10:1281-1289.